News | Catheters | February 09, 2022

Innovative Health Receives Clearance to Reprocess INTELLAMAP ORION High-Resolution Mapping Catheter

Clearance adds important savings for Innovative Health's partner hospitals

Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has received clearance to reprocess Boston Scientific’s INTELLAMAP ORION High-Resolution Mapping Catheter.

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has received clearance to reprocess Boston Scientific’s INTELLAMAP ORION High-Resolution Mapping Catheter. The catheter is widely used in catheter ablation procedures for atrial fibrillation.
 
Innovative Health has built a leading portfolio of FDA clearances to reprocess medical devices in the EP lab and has enabled EP labs across the country to reduce procedure device costs by as much as 30% without compromising patient safety or necessitating treatment adjustments. These savings are strategically important in many EP labs.
 
“EP labs often struggle to pay for new technologies or treat patients under CMS reimbursement, and single-use device reprocessing has presented a strategy for improving care without suffering the usual hardship of cost reduction initiatives,” said Innovative Health CEO Rick Ferreira. “Now, it is up to the EP labs if they want to take advantage of the extra savings.”
 
Innovative Health partner hospitals already save hundreds of thousands of dollars per year by using reprocessed devices from Innovative Health, and in 2021, the number of partner hospitals saving more than $1 million doubled. High-performing hospitals receive Innovative Health’s “Excellence in Electrophysiology” reprocessing award in January and February.
 
Clearance for Boston Scientific’s INTELLAMAP ORION High-Resolution Mapping Catheter means that Innovative Health can now offer every major brand mapping catheter across multiple manufacturers. The FDA clearance can reduce costs by an additional $1,300 in some ablation procedures.
 
For more information: innovative-health.com/

Additional Content

News | Catheters

Nov. 4, 2026 — Evident Vascular has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident ...

Home November 05, 2026
Home
News | Catheters

Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...

Home September 15, 2026
Home
News | Catheters

June 30, 2026 — Penumbra Inc. has received the CE Mark for Red 72 Silver Label and Red 72 Silver Label with SENDit ...

Home July 02, 2026
Home
News | Catheters

Feb. 12, 2026 – CellProthera has acquired the transendocardial catheter originally developed by Celyad Oncology. This ...

Home February 12, 2026
Home
News | Catheters

Oct. 23, 2025— Emboline, Inc., a provider of full-body embolic protection devices for transcatheter procedures, thas ...

Home October 28, 2025
Home
Subscribe Now